The Future of CNS Therapeutics: Innovation, AI, and Personalized Medicine CNS Therapeutics Market Overview 2025–2033 The Global Central Nervous System (CNS) Therapeutics Market is undergoing a significant transformation as neuroscience, biotechnology, and digital innovation converge to address complex neurological and psychiatric disorders. Valued at USD 123.7...

The global healthcare landscape is undergoing a radical shift as software driven medical interventions move from the periphery to the center of clinical practice. The Digital Therapeutics (DTx) market is poised for exponential growth through 2028, driven by the increasing prevalence of chronic diseases, the necessity for cost effective healthcare delivery, and the rapid adoption of smartphone...

Mental health virtual assistants with crisis detection — the NLP algorithms identifying suicidal ideation, self-harm intent, and acute psychiatric decompensation in patient messages with 85-90% sensitivity, triggering immediate human intervention — create the most commercially dynamic market segment, with the Health Intelligent Virtual Assistant Market reflecting crisis support as...

According to the latest report published by Data Bridge Market Research, the Smart Inhaler Technology Market Data Bridge Market Research analyses that the smart inhaler technology market which was USD 57.61 billion in 2021, would rocket up to USD 196.29 billion by 2029, and is expected to undergo a CAGR of 16.56% during the forecast period of 2022 to 2029. Smart Inhaler Technology...

We are witnessing a seismic shift in 2026 as "Digital Therapeutics" (DTx) move into the mainstream of the Software as a Medical Device (SaMD) Market. These are clinically validated software programs designed to treat, manage, or prevent medical disorders. From FDA-cleared apps for ADHD to software-led cognitive behavioral therapy for chronic insomnia, DTx are proving that code can be just as...

US digital therapeutics market size and trajectory — the comprehensive commercial market for prescription digital therapeutics, FDA-cleared digital health applications, and evidence-based digital treatment programs — represents a market at an inflection point between clinical promise and commercial reality, with the US Digital Therapeutics Market reflecting both the market's scale...